Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ono Pharmaceutical CoMEX:4528N 89 Days Inventory is 184.40 as of Jun. 2026, which is 21% above its 10-year median of 152.02. GuruFocus rates MEX:4528N with a GF Score™ of 89/100 and a GF Value™ of MXN311.93. The stock has 2 warning signs investors should review. Among 920 Drug Manufacturers companies, Ono Pharmaceutical Co ranks worse than 54.35% on this metric.
The historical rank and industry rank for Ono Pharmaceutical Co's Days Inventory or its related term are showing as below:
MEX:4528N'
s Days Inventory Range Over the Past 10 Years
Min: 134.15 Med: 152.02 Max: 174.71
Current: 174.71
During the past 13 years, Ono Pharmaceutical Co's highest Days Inventory was 174.71. The lowest was 134.15. And the median was 152.02.
MEX:4528N's Days Inventory is ranked worse than 54.35% of 920
companies
in the Drug Manufacturers industry
Industry Median: 165.16
vs MEX:4528N: 174.71
Ono Pharmaceutical Co's Days Inventory
declined
from Jun. 2025 (184.42) to Jun. 2026 (184.40).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Ono Pharmaceutical Co's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.49.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ono Pharmaceutical Co's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.50.
Ono Pharmaceutical Co (MEX:4528N) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Ono Pharmaceutical Co's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ono Pharmaceutical Co's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Ono Pharmaceutical Co Days Inventory Related Terms
Ono Pharmaceutical Co Days Inventory Historical Data
* Premium members only.
The historical data trend for Ono Pharmaceutical Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:4528N vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ono Pharmaceutical Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Ono Pharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ono Pharmaceutical Co (MEX:4528N) has a Days Inventory of 184.40 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ono Pharmaceutical Co and its competitors. This is 21% above median its historical median of 152.02. Over the past decade, Ono Pharmaceutical Co's Days Inventory has ranged from 134.15 to 174.71. According to the industry distribution chart, Ono Pharmaceutical Co ranks #500 out of 920 companies in the Drug Manufacturers industry, placing it in the top 54.3%.
Is Ono Pharmaceutical Co's Days Inventory too high?
Ono Pharmaceutical Co's current Days Inventory of 184.40 is 21% above median its 10-year median of 152.02. Over the past 10 years, this metric has ranged from a low of 134.15 to a high of 174.71. The Drug Manufacturers industry median Days Inventory is 165.16. Ono Pharmaceutical Co's value of 184.40 is 11.6% above this industry median. Based on the distribution chart, Ono Pharmaceutical Co ranks #500 out of 920 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Ono Pharmaceutical Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Ono Pharmaceutical Co's Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Ono Pharmaceutical Co ranks #500 out of 920 companies for Days Inventory. This places Ono Pharmaceutical Co in the lower half of its industry. The industry median Days Inventory is 165.16. Ono Pharmaceutical Co's value of 184.40 is 11.6% above this benchmark. Historically, Ono Pharmaceutical Co's own Days Inventory has ranged from 134.15 to 174.71 over the past decade. While the company's 10-year median is 152.02 vs. the industry median of 165.16, Ono Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.16, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ono Pharmaceutical Co's current Days Inventory of 184.40 is 11.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ono Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ono Pharmaceutical Co's current Days Inventory is 184.40, which is 21% above median its own 10-year median of 152.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ono Pharmaceutical Co stock overvalued right now?
Ono Pharmaceutical Co (MEX:4528N) has a current Days Inventory of 184.40. The stock's GF Value™ is MXN311.93, compared to a current price of MXN341.69 — trading 9.5% above its estimated fair value. The current Days Inventory is 184.40, which is 21% above median its 10-year median of 152.02 and 11.6% above the Drug Manufacturers industry median of 165.16. Ono Pharmaceutical Co's overall GF Score™ is 89/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Ono Pharmaceutical Co (MEX:4528N), the current Days Inventory is 184.40 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ono Pharmaceutical Co (MEX:4528N) Overvalued in 2026?
Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued.
The current stock price of MXN341.69 is trading 9.5% above its estimated GF Value™ of MXN311.93.
Key valuation signals for MEX:4528N:
Days Inventory: 184.40 (21% above median its 10-year median of 152.02)
GF Value™: MXN311.93 vs. price of MXN341.69 (9.5% above fair value)
Industry Position: 11.6% above the Drug Manufacturers median (#500 of 920)
No single metric tells the full story. See the MEX:4528N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
89GF Score
Get the complete analysis for MEX:4528N
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:4528N has been successfully added to your 
